NorthCrest Asset Manangement’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.41M Buy
58,166
+12,360
+27% +$323K 0.04% 298
2026
Q1
$1.3M Sell
45,806
-12,579
-22% -$335K 0.04% 285
2025
Q4
$1.47M Sell
58,385
-49
-0.1% -$1.24K 0.03% 307
2025
Q3
$1.54M Buy
58,434
+5,331
+10% +$132K 0.04% 271
2025
Q2
$1.35M Buy
53,103
+7,712
+17% +$180K 0.04% 267
2025
Q1
$1.15M Buy
45,391
+6,440
+17% +$169K 0.03% 280
2024
Q4
$1.03M Sell
38,951
-17,115
-31% -$464K 0.03% 290
2024
Q3
$1.62M Sell
56,066
-2,787
-5% -$81.3K 0.05% 224
2024
Q2
$1.65M Sell
58,853
-556
-0.9% -$15.3K 0.05% 217
2024
Q1
$1.65M Buy
59,409
+6,221
+12% +$173K 0.06% 218
2023
Q4
$1.53M Sell
53,188
-443,915
-89% -$13.4M 0.06% 216
2023
Q3
$16.5M Sell
497,103
-23,526
-5% -$832K 0.67% 42
2023
Q2
$19.1M Buy
520,629
+7,913
+2% +$308K 0.76% 34
2023
Q1
$20.9M Buy
512,716
+493,170
+2,523% +$21.3M 0.87% 28
2022
Q4
$1M Sell
19,546
-408,841
-95% -$19.6M 0.06% 189
2022
Q3
$18.7M Buy
428,387
+18,170
+4% +$883K 1.01% 17
2022
Q2
$21.5M Buy
410,217
+5,451
+1% +$278K 1.1% 12
2022
Q1
$21M Buy
404,766
+391,194
+2,882% +$20.3M 0.99% 23
2021
Q4
$801K Buy
+13,572
New +$672K 0.04% 253

Other funds holding PFE

NorthCrest Asset Manangement's PFE Position: Q2 2026 in Review

NorthCrest Asset Manangement increased its Pfizer (PFE) stake by 27% in Q2 2026, buying an estimated $323K and bringing the position to 58,166 shares worth $1.41M. The position accounts for 0.04% of the portfolio, ranked #298.

NorthCrest Asset Manangement first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $21.5M in Q2 2022. 1,303 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • NorthCrest Asset Manangement held 58,166 shares of Pfizer worth $1.41M as of Q2 2026.
  • NorthCrest Asset Manangement bought 12,360 Pfizer shares in Q2 2026, an estimated $323K.
  • Pfizer made up 0.04% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #298 holding.
  • NorthCrest Asset Manangement first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • NorthCrest Asset Manangement's Pfizer position peaked at $21.5M in Q2 2022.
  • 1,303 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.